Dr. Kenneth Olivier, MD

• Radiation Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Fairfield University / Graduate School Of Education And Allied Professions

  Medical School

• Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease, 2016-09-03

• Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases, 2013-06-29

• Feasibility of Proton Transmission-Beam Stereotactic Ablative Radiotherapy versus Photon Stereotactic Ablative Radiotherapy for Lung Tumors: A Dosimetric and Feasibility Study, 2014-06-02

• Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma, 2012-05-03

• PD-1 Restrains Radiotherapy-Induced Abscopal Effect, 2015-02-19

• The clinical case for proton beam therapy, 2012-10-22

• Development and validation of a unifying pre-treatment decision tool for intracranial and extracranial metastasis-directed radiotherapy, 2023-03-27

• Lung tumor motion change during stereotactic body radiotherapy (SBRT): an evaluation using MRI, 2014-05-08

• Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy, 2015-07-26

• Stereotactic Body Radiotherapy for Metastatic and Recurrent Ewing Sarcoma and Osteosarcoma, 2014-12-09

• Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer, 2020-06-11

• Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer, 2016-01-29

• Prospective Immunophenotyping of CD8+T-cells and Associated Clinical Outcomes of Patients with Oligometastatic Prostate Cancer Treated with Metastasis-Directed SBRT, 2018-09-08

• Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer, 2018-12-01

• CD117, BAP1, MTAP, and TdT Is a Useful Immunohistochemical Panel to Distinguish Thymoma from Thymic Carcinoma, 2022-05-05

• Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumors, 2014-09-08

• Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung, 2015-01-14

• Phase II evaluation of Stereotactic Ablative Radiotherapy (SABR) and immunity in11C-Choline-PET/CT-identified oligometastatic castration-resistant prostate cancer, 2021-09-30

• Patterns of recurrence and modes of progression after metastasis-directed therapy in oligometastatic castration-sensitive prostate cancer, 2020-08-14

• Outcomes of Stereotactic Body Radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules, 2015-02-18

• Surgery for Mesothelioma After Radiation Therapy (SMART); A Single Institution Experience, 2020-03-24

• Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy, 2013-07-06

• NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients with Stage I Peripheral Non-Small Cell Lung Cancer, 2015-07-17

• Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer, 2013-01-22